Panbela Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OTC.Pink
Panbela Therapeutics has rescheduled its Special Meeting of Stockholders to May 28, 2024, and is seeking approval for a reverse stock split to meet listing requirements.
OTC.Pink
Panbela Therapeutics issues preferred stock to its Chairman, plans for CBOE listing, and postpones special meeting due to Nasdaq delisting.
OTC.Pink
DEF 14A: Panbela Therapeutics Seeks Stockholder Approval for Reverse Stock Split to Regain Nasdaq Compliance
Panbela Therapeutics is asking stockholders to approve a reverse stock split to increase its stock price and meet Nasdaq's listing requirements.